Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dade RONG"'
Autor:
Wanhua Cai, Dade Rong, Jiayu Ding, Xiaomei Zhang, Yuwei Wang, Ying Fang, Jing Xiao, Shulan Yang, Haihe Wang
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Microtubule polymerization is usually considered as the upstream of apoptotic cell death induced by taxanes, but recently published studies provide more insights into the mechanisms responsible for the antineoplastic effect of tax
Externí odkaz:
https://doaj.org/article/cb2d25d1f4fe429291e1fa9d88ce13bb
Autor:
Dongbo Guo, Josh Haipeng Lei, Dade Rong, Tesen Zhang, Bohan Zhang, Zikang Tang, Han‐Ming Shen, Chu‐Xia Deng, Songnan Qu
Publikováno v:
Advanced Science, Vol 9, Iss 36, Pp n/a-n/a (2022)
Abstract Rapid, efficient, and precise cancer therapy is highly desired. Here, this work reports solvothermally synthesized photoactivatable Pt(IV)‐coordinated carbon dots (Pt‐CDs) and their bovine serum albumin (BSA) complex (Pt‐CDs@BSA) as a
Externí odkaz:
https://doaj.org/article/e4ddc3bfca2c4421bdfbd50cadbe580f
Publikováno v:
Heliyon, Vol 8, Iss 9, Pp e10610- (2022)
Objective: We tried to identify novel molecular subtypes of acute myeloid leukemia (AML) associated with histone methylation and established a relevant scoring system to predict treatment response and prognosis of AML. Methods: Gene expression data a
Externí odkaz:
https://doaj.org/article/903b1fb5ba894ca49e7ad3a97476bc68
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Background: Generally, hepatocellular carcinoma (HCC) exists in an immunosuppressive microenvironment that promotes tumor evasion. Hypoxia can impact intercellular crosstalk in the tumor microenvironment. This study aimed to explore and elucidate the
Externí odkaz:
https://doaj.org/article/41d28a0ae38742cdbad0c57515be9fd6
Autor:
Daiyuan Liu, Shulan Yang, Mingming Zhang, Yanbin Liu, Adam Taouil, Yanli Wei, Haihe Wang, Saleh Abdul Momen Ali, Xiaomei Zhang, Haider Farhan, Wanrong Guo, Dade Rong, Iwao Ojima, Changwei Wang, Yican Wang
Publikováno v:
Cancer Letters. 491:36-49
Paclitaxel (PTX) is widely used to treat breast and ovarian cancers, but innate and acquired resistance often compromises its applications. The objective of this study was to screen new-generation taxanes for their efficiency against both PTX-sensiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eff23b2c993e2095dd05b7bcfe3986d2
https://doi.org/10.1016/j.canlet.2020.06.025
https://doi.org/10.1016/j.canlet.2020.06.025
Autor:
Shaoyang Zhang, Xiufeng Liu, Saleh Abdulmomen Ali Mohammed, Hui Li, Wanhua Cai, Wen Guan, Daiyun Liu, Yanli Wei, Dade Rong, Ying Fang, Farhan Haider, Haimei Lv, Ziwei Jin, Xiaomin Chen, Zhuomao Mo, Lujie Li, Shulan Yang, Haihe Wang
Publikováno v:
Autophagy. 18(8)
Acquired chemotherapy resistance is one of the main culprits in the relapse of breast cancer. But the underlying mechanism of chemotherapy resistance remains elusive. Here, we demonstrate that a small adaptor protein, SH3BGRL, is not only elevated in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64086b87634a4156d58ef92b1e805aa1
https://pubmed.ncbi.nlm.nih.gov/34870550
https://pubmed.ncbi.nlm.nih.gov/34870550
Publikováno v:
Anti-cancer agents in medicinal chemistry. 22(12)
Background: SH3-domain-binding glutamic acid-rich protein-like protein (SH3BGRL) is downregulated in acute myeloid leukemia (AML). Clinically, DNA demethylating drug decitabine (DAC) combined with traditional chemotherapies reveals better efficacy on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89916467b4b2983d4c9f8a41fa032832
https://pubmed.ncbi.nlm.nih.gov/34963436
https://pubmed.ncbi.nlm.nih.gov/34963436
Background: Acute myeloid leukemia (AML) is a type of heterogeneous disease with varied prognosis, but current classification methods for AML do not play an ideal role in guiding the therapy. Emerging studies shown alteration of histone methylation i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff7256a71b4c13a35ca7bcb6b2ece44f
https://doi.org/10.21203/rs.3.rs-629632/v1
https://doi.org/10.21203/rs.3.rs-629632/v1
Publikováno v:
Neoplasma. 68(4)
Phosphatase of regenerating liver-3 (PRL-3) is recognized as a novel independent crucial driver for AML progression. Thus, the specific inhibitor of PRL-3 would be a potential therapeutic agent to AML in clinics, but there are not enough preclinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa8e41ec8792180bba5c4a1570125196
https://pubmed.ncbi.nlm.nih.gov/34348467
https://pubmed.ncbi.nlm.nih.gov/34348467
Phosphatase of regenerating liver-3 (PRL-3) is recognized as a novel independent crucial driver for AML progression. Thus, the specific inhibitor of PRL-3 would be a potential therapeutic agent to AML in clinic, but there is no such preclinical appli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::377c9a3d68ea6b415d6028eb8bf8e381
https://doi.org/10.21203/rs.3.rs-191026/v1
https://doi.org/10.21203/rs.3.rs-191026/v1